Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH; American Society of Clinical Oncology..

J Clin Oncol. 2011 Nov 1;29(31):4189-98. doi: 10.1200/JCO.2010.34.4614. Epub 2011 Sep 26. Review. Erratum in: J Clin Oncol. 2014 Jun 1;32(19):2117. Dosage error in article text.

2.

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

American Society of Clinical Oncology., Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM.

J Clin Oncol. 2006 Jun 20;24(18):2932-47. Epub 2006 May 22. Erratum in: J Clin Oncol. 2006 Nov 20;24(33):5341-2.

PMID:
16717289
3.

Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapy.

Celio L, Agustoni F, Testa I, Dotti K, de Braud F.

Tumori. 2012 May-Jun;98(3):279-86. doi: 10.1700/1125.12393. Review.

4.

Clinical update on palonosetron in the management of chemotherapy-induced nausea and vomiting.

Celio L, Denaro A, Canova S, Gevorgyan A, Bajetta E.

Tumori. 2008 Jul-Aug;94(4):447-52. Review.

5.

An update on palonosetron hydrochloride for the treatment of radio/chemotherapy-induced nausea and vomiting.

Fabi A, Malaguti P.

Expert Opin Pharmacother. 2013 Apr;14(5):629-41. doi: 10.1517/14656566.2013.771166. Epub 2013 Feb 18. Review.

PMID:
23414148
6.

Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Phillips RS, Friend AJ, Gibson F, Houghton E, Gopaul S, Craig JV, Pizer B.

Cochrane Database Syst Rev. 2016 Feb 2;2:CD007786. doi: 10.1002/14651858.CD007786.pub3. Review.

PMID:
26836199
7.

Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.

Kris MG, Tonato M, Bria E, Ballatori E, Espersen B, Herrstedt J, Rittenberg C, Einhorn LH, Grunberg S, Saito M, Morrow G, Hesketh P.

Support Care Cancer. 2011 Mar;19 Suppl 1:S25-32. doi: 10.1007/s00520-010-0976-9. Epub 2010 Aug 28.

PMID:
20803039
8.

[Medical treatment of chemotherapy-induced nausea and vomiting].

Herrstedt J.

Ugeskr Laeger. 2007 Feb 26;169(9):799-805. Review. Danish.

PMID:
17355844
9.

Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009.

Jordan K, Roila F, Molassiotis A, Maranzano E, Clark-Snow RA, Feyer P; MASCC/ESMO..

Support Care Cancer. 2011 Mar;19 Suppl 1:S37-42. doi: 10.1007/s00520-010-0994-7. Epub 2010 Sep 9.

PMID:
20824481
10.

Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.

Navari RM.

J Support Oncol. 2003 Jul-Aug;1(2):89-103. Review.

PMID:
15352652
11.

New antiemetic drugs.

Roila F, Fatigoni S.

Ann Oncol. 2006 Mar;17 Suppl 2:ii96-100. Review.

PMID:
16608997
12.

Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy.

Ellebaek E, Herrstedt J.

Curr Opin Support Palliat Care. 2008 Mar;2(1):28-34. doi: 10.1097/SPC.0b013e3282f44a75. Review.

PMID:
18685391
13.

Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.

Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K, Pizer B.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007786. doi: 10.1002/14651858.CD007786.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;2:CD007786.

PMID:
20824866
14.

Emerging drugs for chemotherapy-induced emesis.

Navari RM, Province PS.

Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51. Review.

PMID:
16503832
15.

Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).

Roila F, Warr D, Aapro M, Clark-Snow RA, Einhorn L, Gralla RJ, Herrstedt J, Saito M, Tonato M.

Support Care Cancer. 2011 Mar;19 Suppl 1:S57-62. doi: 10.1007/s00520-010-1039-y. Epub 2010 Dec 5.

PMID:
21132332
16.

Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?

Schwartzberg LS.

Oncology (Williston Park). 2007 Jul;21(8):946-53; discussion 954, 959, 962 passim. Review.

17.

Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting.

Lorusso V, Karthaus M, Aapro M.

Future Oncol. 2015;11(4):565-77. doi: 10.2217/fon.14.260. Epub 2014 Oct 31. Review.

PMID:
25360998
18.

Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron).

Rojas C, Slusher BS.

Cancer Treat Rev. 2015 Dec;41(10):904-13. doi: 10.1016/j.ctrv.2015.09.005. Epub 2015 Sep 26. Review.

PMID:
26442475
19.

Prevention of emesis from multiple-day and high-dose chemotherapy regimens.

Navari RM.

J Natl Compr Canc Netw. 2007 Jan;5(1):51-9. Review.

PMID:
17239326
20.

Antiemetic control: toward a new standard of care for emetogenic chemotherapy.

Navari RM.

Expert Opin Pharmacother. 2009 Mar;10(4):629-44. doi: 10.1517/14656560902731894 . Review.

PMID:
19284365

Supplemental Content

Support Center